Femi Adewunmi, MD, leads clinical operations of the Atlantic region. His responsibilities include regional organizational leadership and operational performance. In his role, Dr. Adewunmi works directly with our hospital partners and hospitalists along with the regional vice president of operations to ensure the delivery of high-quality patient care and the alignment of performance with partner hospital goals.
Femi holds a Master of Business Administration degree and a Certificate in Health Sector Management from the Fuqua School of Business at Duke University. He is recognized as a Senior Fellow in the Society of Hospital Medicine (SHM) and served on the SHM's leadership committee and as a facilitator at the organization's Leadership academy. He is also recognized as a Certified Physician Executive by the American College of Physician Executives. He completed his internal medicine residency at Abington Memorial Hospital in Abington, Pa. and graduated from the University of Ibadan's College of Medicine in Nigeria.
Drew Baker is Director of Health Policy & Reimbursement for Stryker Corporation, a Top 10 medical technology company. His responsibilities include technology assessment, health economic strategy development and execution, and value evidence generation to support commercialization and market access across all of Stryker’s operating divisions and global markets. Drew has extensive experience operating in and consulting to the provider, payer and life sciences industries. Prior to joining Stryker, he led initiatives in the areas of commercial opportunity assessment, product and service development, health technology assessment, and comparative effectiveness and outcomes research. He spent 15 years with Pfizer and was a founding member of the company's Global Outcomes Research function. He's also served as an executive with several health care management consulting firms.
Drew has published and presented extensively in the areas of medical technology value estimation, healthcare quality and health policy. His articles have appeared in such publications as PharmacoEconomics, Pharmaceutical Executive and The Wall Street Journal. Drew has also served as a peer reviewer for the Journal of Clinical Psychiatry and frequent Guest Lecturer at MIT’s Sloan School of Management. While at Pfizer, Drew received the American College of Medical Quality's Institutional Achievement Award for his development and implementation the first biopharmaceutical industry medical affairs program to assist health care organizations enhance quality of care.
Drew holds an MBA from Duke University, a Master of Public Affairs (MPA) degree from Princeton University, and BA and BS degrees from Syracuse University. Drew also completed graduate coursework in medical technology evaluation and clinical decision analysis at the Harvard School of Public Health.
Mr. Baker joined Alcobra in January 2014 as the Chief Commercial Officer. Prior to joining Alcobra, he worked at Shire for 10 years, most recently as Vice President of Commercial Strategy and New Business in the Neuroscience Business Unit. In that role, he led the commercial assessment of neuroscience licensing opportunities, managed commercial efforts on pipeline CNS products, and led the long term strategic planning process. Previously, he served as Global General Manager for Vyvanse® where he led the launch of Vyvanse, led the launch of the adult indication for Vyvanse, and led global expansion efforts including successful establishment of a partnership in Japan and launches in Canada and Brazil. Prior to that, Mr. Baker served as Vice President of Marketing for all of Shire's ADHD products. He has been directly involved with the commercialization of five approved ADHD medications.
From 1990 - 2004, Mr. Baker worked at Merck where he held positions of increasing responsibility in marketing, sales, market research, and business development. In addition to his knowledge and experience with CNS medications, Mr. Baker's therapeutic expertise includes osteoporosis, migraine, and hyperlipidemia. He has been directly involved with the marketing of five medications with annual sales in excess of $1 billion each.
Mr. Baker graduated Magna Cum Laude with a bachelor's degree in Economics and Computer Science from Duke University. He earned a Master of Business Administration in Marketing from Duke's Fuqua School of Business.
Sharon Bracken is the divisional vice president, operations, at Abbott Diagnostics.At Abbott since 2005, Sharon has held positions of increasing responsibility, including overseeing operations at Abbott sites in the US and Europe. Sharon's hallmark is delivering results. She has contributed substantial financial and quality improvements to Abbott's business while taking an active role in the Women Leaders in Action employee network. She generously gives time to mentoring and supports college recruiting initiatives to build Abbott's talent pipeline.
Leigh Ann Bruhn, Director at Avalere Health, advises clients on market access, product commercialization and value strategy. In her prior pharmaceutical and medical device career, she led initiatives across healthcare stakeholders including commercial payers, providers, retail pharmacy, specialty pharmacy and patient advocacy.
Prior to joining Avalere, Leigh Ann was a Director of Managed Care Marketing at Abbott Pharmaceuticals. Her work spans public and primary payers as well as both primary care and specialty products. Leigh Ann is a frequent speaker on accountable care organizations, payment and delivery reform and specialty pharmaceuticals/specialty pharmacy and a committee member for the National Association of Specialty Pharmacy (NASP).
Leigh Ann has a BS in Finance from the University of Illinois at Urbana-Champaign and a MBA in Health Sector Management the Duke University Fuqua School of Business. She always enjoys opportunities to connect with the growing Fuqua community.
Laura Crandon is Vice President, Strategic Alliances and Business Development at UnitedHealth Group. Laura is responsible for leading a portfolio of enterprise-to-enterprise relationships including AARP Federal Programs, Ameriprise, Walmart, Walgreens and Kroger, among others. She develops new business categories and drives differentiation by identifying, building and managing alliances that deliver on the mission to help people live healthier lives. Laura leads a team that delivers growth, innovation, clinical quality and member engagement, in collaboration with alliance relationships.
Prior to joining UnitedHealth Group, Laura founded a sales and marketing consulting firm focused on measurably improving client loyalty and retention, serving clients including eBay and UnitedHealthcare. Laura previously held positions as Vice President of Sales and Sales Operations, and General Manager at successive start-ups where her focus was client acquisition and engagement worldwide. During her tenure, the business segment she founded and led doubled in size and became the most profitable amongst its peers. She previously held leadership positions in Europe and the United States with GE while a member of its Corporate Audit Staff.
Laura earned an MBA from Duke University (Weekend Executive) and a BS in Computer Science from the University of Maryland at College Park. She has served in an advisory capacity on the Coalition to Transform Advanced Care, whose vision is that all Americans with advanced illness, especially the sickest and most vulnerable, will receive comprehensive, high-quality, patient-centered care that is consistent with their goals and values and honors their dignity. Laura is a member of the National Association of Health Services Executives and the American College of Healthcare Executives. She serves as Vice Chair of The Johnson C. Smith Theological Seminary Board of Trustees, and is an alumnus of INROADS, Inc. She holds a United States Patent for client management methodology and has received numerous awards for innovations featured in The Wall Street Journal and PC Week. Laura has a passion for improving health outcomes and meeting individuals' health needs.
Since September of 2013, Todd has been the CFO and Treasurer of ZS Pharma, a public company (NASDAQ:ZSPH) developing and manufacturing inorganic compounds to treat renal and cardiovascular diseases. In June of 2014, ZS Pharma completed a $123m IPO and has since been one of the top 10 performing companies of the 2014 IPO class. He was the CFO and Vice-President of Business Development for Sarcode Biosciences from 2010-2013. SarCode developed LFA-1 antagonists to treat diseases in ophthalmology, dermatology and other inflammatory conditions. Sarcode was sold to Shire Pharmaceuticals in April 2013 for $160m up front and significant additional development and revenue milestones. From January 2007 through September 2010, Todd was the CFO of Sirion Therapeutics, a private company that developed and marketed ophthalmic pharmaceuticals. Sirion raised over $100 million in debt and equity during that time to support the license and development of six late-stage clinical programs; two of which were eventually approved by the FDA and commercialized by Sirion. In the first half of 2010 he helped lead the sale of Sirion's drug assets to Alcon and Bausch and Lomb. His responsibilities while working for these companies have included; financing strategy and fundraising, business development, accounting, capital structure, treasury, legal, human resources and information technology activities.
Prior to Sirion, Todd worked with NovaQuest, the former investment group within Quintiles. There he structured, placed and managed capital investments into U.S. emerging biotech and specialty pharmaceutical companies, including the investment that launched Sirion Therapeutics. Todd co-founded Centice, an optical sensor spin-out from Duke University in 2003. He further has over 10 years of experience consulting to pharmaceutical, biotech and high-tech companies, from startups to Fortune 100 firms, while at SRI International and Andersen Consulting. Todd holds bachelor's degrees in Finance and Accounting from Miami (Ohio) University and an MBA from Duke University. He and his wife, Heather, live in Tampa, Florida, and have two children: Ty (9) and Caden (7).
Robyn Eckermann is the Vice President of Strategy for Rallyhood, a community and customer support platform redefining how organizations support and track engagement. For the eight years prior to joining Rallyhood, Robyn was the Vice President of Strategic Planning for HCA’s Central and West Texas Division, which encompasses St. David’s HealthCare in Austin, Texas and Las Palmas Del Sol Healthcare in El Paso, Texas. Under her strategic direction, the Division achieved 68% growth in net revenue despite nearly 45% increase in competition and was recognized with the Malcolm Baldrige National Quality Award. In fact, Robyn was a featured speaker in strategic planning at the annual Malcolm Baldrige conference due to her contributions at St. David’s HealthCare. Robyn also has extensive experience in healthcare consulting - both as an internal consultant within HCA Strategic Resource Group and as an external consultant with the The Camden Group. Robyn chairs the Women’s Leadership Council of United Way, the Continued Learning Committee of Duke’s Healthcare Alumni Advisory Board and serves as an Advisor to SoftMatch. Robyn earned her undergraduate degree at UCLA and holds an MBA with a concentration in Health Sector Management from Duke University. She and her husband, Kyle, attended Fuqua together and have two boys.
Rich obtained his B.A. and M.D degrees from The Johns Hopkins University and completed his surgical residency at the Massachusetts General Hospital. Rich practiced academic cardiothoracic surgery for more than twenty years before entering his current position, and has been a faculty member at the University of Iowa, Virginia Commonwealth University, Texas Tech Health Sciences Center, Southern Illinois University and Duke University.
Rebecca Fish is the Vice President of Marketing at Emergent BioSolutions. Emergent is a global leader in the development of medical countermeasures against biological and chemical threats including anthrax, smallpox and botulism. Rebecca has senior level health care experience working in both the public and private sectors. In her last role, Rebecca served as the Senior Policy Advisor to The Deputy Assistant Secretary of Health within the Department of Health and Human Services. She led the Vaccine Policy, Science, and Strategy Team and her responsibilities included development of the U.S. National Adult Immunization Plan. She also previously worked within the Centers for Medicare and Medicaid services developing new strategies for drug reimbursement policy (AWP reform) and Medicare Part D and Part B.
Prior to joining HHS, Rebecca worked at GlaxoSmithKline as the Global Head of Medical Countermeasures. She also served as the Executive Director of Vaccine, Antibiotic, and Biodefense Policy at GSK and managed GSK's vaccine business with the Centers for Disease Control. Rebecca held similar marketing roles at Merck & Co., Inc., where she was employed for 8 years and managed the federal and city/county/state vaccine business. She has managed customer segments with approximately $1 billion in annual sales goals.
Rebecca graduated with a high honors degree in Psychobiology from Mount Holyoke College and received her M.B.A. from Duke University's Fuqua School of Business. She completed a Fellows program in Biosecurity through the University of Pittsburgh Medical Center and recently published a paper on a new business model for health security in the Journal of Global Health Diplomacy. Rebecca plans to begin her doctoral degree in public health and health security in the Fall of 2016.
Jeanne Garner is a Senior Qualitative Market Researcher with ZS Associates, a global sales and marketing services firm, with over a decade of strategic, qualitative consulting experience. Jeanne has performed primary and secondary research for leading pharmaceutical companies, biotech firms, clinical operations organizations and the investment community across the spectrum of therapeutic areas amongst the full range of healthcare constituents from global Thought Leaders to community physicians, allied health, patients and payers. Jeannie has moderated primary research in many of the leading global markets, including US, Western Europe, Japan, South America and Eastern Europe. While active in the free-lance consulting field for a number of years, Jeannie also has experience in finance and systems application for a major package goods/consumer health care concern. Jeannie earned her undergraduate AB degree from the University of Georgia and completed her MBA at the Fuqua School of Business. Jeannie lives in Lawrenceville, NJ with her family.
Larry has spent the last 25 years growing and building healthcare businesses as an operator, owner, investor and investment banker. Immediately following graduation from Fuqua, he was the 12th corporate employee at MedCath, the Welsh Carson backed heart hospital company and later founded and ran National Vascular Care, a specialty surgery center company backed by Weston Presidio, that was sold to Fresenius Medical. Larry was also a General Partner in the venture capital firm Kitty Hawk Capital and led healthcare M&A for Marks Baughan & Co. Larry is currently the CEO of both Clinical Difference, an online medical education company, and Lawrence Capital LLC a healthcare focused consulting and advisory services business.
Laurie Gomer is a Sales Executive at Syapse, a social+capital and Safeguard Scientific venture-backed company, whose precision medicine data platform integrates genomic and clinical data to provide clinicians with actionable insights at point of care, enabling diagnosis, treatment, and outcomes tracking. Previously, she was Director of Business Development at AppMedicine, a healthcare mobile app and communication platform, which used mobile technology to improve patient access to high-quality, cost-effective medical care outside of the doctor's office. Prior to AppMedicine, Laurie worked in Pipeline and Portfolio Planning at Genentech and Business Development at Navigenics (Acquired by Life Technologies/Thermo Fisher), a personal genomics company, which was venture-backed by Kleiner Perkins Caufield & Byers, Mohr Davidow Ventures, and Procter & Gamble. Before joining Navigenics, Laurie worked as a Research Manager in the Healthcare & Biomedical Practice at Gerson Lehrman Group, a primary investment research firm for institutional investors, venture capital and private equity firms. Laurie began her career as a Consultant at The Lucas Group, a boutique management consulting firm, where she was a member of the firm's Growth and Acquisitions Practice and assisted with multiple due diligence engagements for private equity firms and corporations. Laurie earned a BA from Davidson College and an MBA from The Fuqua School of Business at Duke University.
Lucy is a principal and co-founder of H.O.P.E Management, a specialty consulting firm. H.O.P.E combines the business and clinical aspects of healthcare to create unique solutions and business models that improve the operational and financial performance of hospitals and healthcare providers. Lucy is currently leading the Clinical and Business Intelligence group, which is comprised of strong believers in the innovative use of data and technology in hospital management. Prior to H.O.P.E, she was a partner at Apex Healthcare Consulting and a project manager at CSC Consulting, Global Health Solutions. Lucy has touched many aspects of healthcare arena. She was a volunteer, clinical instructor, nurse and care unit manager before she became a consultant. Lucy obtained her Bachelor in Medicine from Beijing Medical University and graduated from Fuqua in 2004, and is certified in Health Sector Management.
Lucy is an enthusiastic traveller. She and her family have visited over 20 countries spanning three continents. Lucy lives with her husband and three daughters, Grace-Rae (13), Aubry (1) and Avery (1) in Edison, NJ.
Following graduation from Fuqua, Rob accepted a position to work at Eli Lilly and Company. Currently, Rob is a Director of Finance for the Lilly BioMedicines Business Unit and serves in consolidating Global Business Unit Performance and is the CFO for Development within the Business Unit. Additionally, he facilitates business development transactions as they evolve and manages the financial integration following deal execution. Prior to this position, Rob was a director in the Mergers and Acquisitions group, a Six Sigma Black Belt and worked as the Debt Capital Markets Analyst in Treasury. Prior to Fuqua, Rob worked for five years as a Molecular Biologist at Pfizer and for one year at Affymax. He has a BS in Human Biology from the University of Wisconsin-Green Bay and a MS in Microbiology from Miami University.
Ken Pittman currently serves as Chief Operating Officer/Director of Administration for the Campus Health Services of the University of North Carolina-Chapel Hill, an 80,000-visit, 200-employee multi-specialty outpatient healthcare organization. He has previously served as a hospital turnaround CEO for financially and operationally challenged hospitals in Texas, Georgia and Alabama; COO of a 300-bed community hospital in eastern North Carolina; and a hospital management consultant with Premier Inc. He has also served as an Adjunct Instructor for the East Carolina University School of Business.
Ken is a Fellow of the American College of Healthcare Executives and is a member of the Triangle Healthcare Executives Forum. Ken is also a member of the American College Health Association. In addition to his membership on the Fuqua Healthcare Alumni Advisory Board, his Duke service and involvement includes the James B. Duke Society, the Congregation at Duke University Chapel and the Iron Dukes. Through the years, he has served his community as President of the Chamber of Commerce, the Community Council for the Arts, the local chapter of the American Red Cross, and the Boys and Girls Club.
Ken and his partner James,a clinical psychologist, reside in Durham with their two daughters. The eldest is a 2014 graduate of Elon and the youngest is a senior biology major at NC State.
Kevin Schelenski is an Engagement Manager for Axia Limited, a Healthcare, Life Sciences, and Consumer Goods consulting firm based in Boston, MA. Over his career, Kevin has led several high-impact, strategic engagements including a comprehensive financial and operational turnaround for a major academic health system, go-to-market strategy design, customer segmentation strategy design and subsequent strategy implementations for leading medical device and healthcare services corporations, and operational planning and cost management for pharma and biopharma companies. Kevin has direct experience in a breadth of financial, operational, and policy driven areas such as patient flow, patient experience, strategic sourcing, operating room and procedure suite optimizations, ambulatory clinic management, network development, funds flow, clinician compensation models, diagnostic services, health system performance management, etc. etc.
Prior to joining Axia, Kevin worked for the Carlisle and Gallagher Consulting Group in Charlotte, NC specializing in the development and deployment of top-line growth and customer acquisition/retention initiatives within financial services.
Kevin holds a bachelor's degree in economics from Yale University and an MBA from the Fuqua School of Business with a certificate in Health Sector Management.
Todd Schwarzinger is a managing director in the Life Sciences Group at Hercules Technology Growth Capital, the largest non-bank lender to venture capital-backed companies at all stages of development in the technology, energy technology, and life science sectors, where he focuses on the firm’s investment activities in the live sciences sector. Mr. Schwarzinger has more than 15 years of investment banking and consulting experience with healthcare and life sciences companies. Prior to joining Hercules in 2015, Mr. Schwarzinger was an Executive Director in the healthcare investment banking division at Morgan Stanley where he advised a broad range of medical device and biopharmaceutical clients on mergers and acquisitions, initial public offerings, the equity and debt capital markets. In his nearly nine year career at Morgan Stanley across both London and New York, he was responsible for life sciences M&A transactions totaling over $5 billion and raised over $3 billion in capital markets transactions spanning North America, Europe and Asia. Prior to Morgan Stanley, Mr. Schwarzinger was a consultant for five years with Accenture in the healthcare sector, focused on supply chain management. Schwarzinger received his MBA from the Fuqua School of Business at Duke University and graduated with a BS in Finance from Miami University.
Chair, Health Care Alumni Advisory Board
Rina Shah is a health care professional who has worked in a number of different capacities across the industry since graduating from the University of North Carolina at Chapel Hill with a degree in Health Policy and Administration. She currently works for Beacon Laboratory Benefits Solutions, a subsidiary of LabCorp, as Vice President of Clinical Programs. The company is a start-up that is working with health plans to improve cost efficiencies in the laboratory testing space while also demanding higher quality. Rina has been responsible for leading and developing the company's clinical program, in addition to playing an integral role in sales activities to new clients, development of new products, and design and testing of the IT platform.
Before her role at BeaconLBS, Rina obtained her MBA from Duke's Fuqua School of Business with concentrations in Health Sector Management and Marketing. While in business school, she interned at Genentech, working to improve patient access to medications. Prior to getting her MBA, Rina was a health consultant at Deloitte Consulting and with her own company. As a consultant she worked with a variety of clients in the payer and provider space, focusing on revenue cycle operations, EMR and other system integrations, and utilization management.
Rina is also a founder and current member of both the Summerbridge Breakthrough Alumni Network Board and the Fuqua Health Care Alumni Advisory Board.
Shane Stoyer is a Managing Consultant with The Lewin Group, a premier national health care and human services consulting firm. He has 20 years of experience in health care, with a focus on operations management, linked database development and analytics. He is a certified Project Manager (PMP) and a member of the Healthcare Information and Management Systems Society (HIMSS).
With The Lewin Group, Mr. Stoyer manages the ASPE (Assistant Secretary for Planning and Evaluation) Medicaid Prescription Drug Simulation Project under the U.S. Department of Health and Human Services. Since early 2014 he has been heavily involved in supporting State Health Benefits Exchanges across the US. He worked as the Operational Lead for Escalations on the Massachusetts Health Insurance Exchange remediation project, in addition to contributing technical, policy and operational expertise. He also served as the Program Manager for a cross-functional team providing operational support and stabilization for the Hawaii Health Connector.
In his previous work with Optum, Mr. Stoyer was a project manager and manager of operations within the Government Services division. He was part of the leadership team of the Multi-Payer Claims Database Project, responsible for database operations, data migration and transformation validation, technical design and implementation, and the creation of de-identified datasets and related procedures. Mr. Stoyer was the operations manager on the North Carolina Medicaid Decision Support System Project where he coordinated all support and maintenance activities, implemented numerous quality assurance and control measures, and oversaw the evaluation and change management processes. He also provided technical supervision and the knowledge transfer on SAS, SQL, data warehousing, and business topics to the State's Medicaid staff.
Mr. Stoyer graduated from Bates College with a BA in Economics. He earned his MBA, along with a Certificate in Health Sector Management, from Duke's Fuqua School of Business (Weekend Executive). He lives north of Durham in rural North Carolina, along with his wife Katherine and daughter, Rainer.
Sam Taggard is a Director of Operations within Cigna's Total Health and Network Organization. In his current role, Sam's focus is to deliver enterprise strategic capabilities. Previously he was a Business Development Project Manager, developing new businesses and strategic partnerships. He also assisted in the creation of Cigna Ventures, Cigna's corporate venture capital fund. During his initial role at Cigna, Sam helped lead National Contracting vendor implementations to support enterprise cost and quality initiatives.
Prior to joining Cigna's HealthService Leadership Program in 2009, Sam practiced Physical Therapy in a variety of clinical settings while at Beth Israel Deaconess and HCA's Portsmouth Regional Hospital.
Sam attained a BS in Economics and Finance from Bentley College as well as a Doctor of Physical Therapy and Master of Business Administration from Duke University.
Co Chair, Health Care Advisory Alumni Board
Wendy Webster is a Divisional Administrator at Duke University Medical Center in the Department of Surgery and brings more than 15 years' experience in health care operations management of teams in the provider and hospital settings. Recognized for her leadership in clinical operations and strategy, she consistently creates performance and cultural transformations.
Additionally, Wendy is active in the triangle community and has lead non-profit organizations such as Girls on the Run of the Triangle and The Junior League of Raleigh.
Wendy received her undergraduate degree from Baylor University and her master's degree from East Carolina University followed by a master's in business administration from Duke's Fuqua School of Business.
Mr. Welch is both a founder of Best Practices Insurance Services, LLC (BPIS) and Applied Medico-Legal Solutions Risk Retention Group, Inc. (AMS RRG). He currently serves as President and Chief Executive Officer of BPIS and President of AMS RRG. Since 2003, AMS RRG has been providing medical professional liability insurance to physicians throughout the country across a broad range of specialties, and is now one of the nation's premier physician risk retention groups with over 2,500 insureds. Mr. Welch is also an owner and President of Global Stage Limited, a member of Lloyd's of London. Additionally, he invests in health sector innovation and participates in Health Wildcatters, a Dallas, Texas based healthcare business incubator.
As a leader in the healthcare industry, Mr. Welch served in executive positions throughout his career. Prior to his current positions, Mr. Welch was a founder, President and CEO of Applied Medical Solutions, Inc. (AMS), a hospitalist company located in South Florida. Mr. Welch merged AMS into one of the nation's leading hospitalist companies and served as Vice President, Operations and Business Development for the Southeast Region. Prior to founding AMS, Mr. Welch served as the Vice President, Operations for the North Broward Hospital District, a multi-hospital system located in South Florida.
Mr. Welch received his Bachelor of Science degree in Business Management from the Florida State University and his Master of Health Administration from Duke University. Mr. Welch has served on numerous charitable boards as well as several professional healthcare organizations. Currently he serves on the Broward Center for the Performing Arts Foundation Board as Treasurer, is a member of YPO and a member of the Broward Workshop. He resides in Fort Lauderdale, Florida with his wife Christine. They have two sons, Alexander and Ryan.